Variant report
Variant | esv3358111 |
---|---|
Chromosome Location | chr1:193308994-193309943 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:193296415..193298204-chr1:193307426..193309237,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573119718 | chr1:193309000-193309001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11381887 | chr1:193309010-193309011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376740956 | chr1:193309011-193309012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539564066 | chr1:193309028-193309029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6702762 | chr1:193309045-193309046 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs545987154 | chr1:193309051-193309052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535133926 | chr1:193309071-193309072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564382059 | chr1:193309138-193309139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376537498 | chr1:193309263-193309264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148332900 | chr1:193309264-193309265 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540386370 | chr1:193309308-193309309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541746669 | chr1:193309365-193309366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560316061 | chr1:193309409-193309410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576898918 | chr1:193309421-193309422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545905833 | chr1:193309438-193309439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369498917 | chr1:193309444-193309445 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531707483 | chr1:193309457-193309458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548338681 | chr1:193309468-193309469 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186271843 | chr1:193309582-193309583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs527589468 | chr1:193309587-193309588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141414241 | chr1:193309599-193309600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546869232 | chr1:193309610-193309611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4657855 | chr1:193309614-193309615 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs549826320 | chr1:193309625-193309626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530088488 | chr1:193309699-193309700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569698072 | chr1:193309716-193309717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535423111 | chr1:193309734-193309735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548420967 | chr1:193309752-193309753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564762776 | chr1:193309766-193309767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555076287 | chr1:193309822-193309823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569785262 | chr1:193309839-193309840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9970143 | chr1:193309860-193309861 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs9887786 | chr1:193309871-193309872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138724292 | chr1:193309919-193309920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113139464 | chr1:193309924-193309925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74481002 | chr1:193309934-193309935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 21062444 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:193305800-193317200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr1:193306800-193309000 | Enhancers | Osteobl | bone |
3 | chr1:193307600-193310800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr1:193308000-193310400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr1:193308000-193310400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
6 | chr1:193308000-193317400 | Weak transcription | HSMM | muscle |
7 | chr1:193308200-193310600 | Weak transcription | NHDF-Ad | bronchial |
8 | chr1:193308400-193309000 | Enhancers | HUVEC | blood vessel |
9 | chr1:193308400-193309800 | Enhancers | Fetal Intestine Large | intestine |
10 | chr1:193308400-193311600 | Enhancers | Fetal Intestine Small | intestine |
11 | chr1:193309400-193309600 | Enhancers | Duodenum Mucosa | Duodenum |
12 | chr1:193309600-193310600 | Weak transcription | Duodenum Mucosa | Duodenum |
13 | chr1:193309800-193310200 | Weak transcription | Fetal Intestine Large | intestine |